|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 270 studies with search of: | Cytomegalovirus Infection |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection
|
||||
| 2 | Completed |
A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
|
||||
| 3 | Completed |
Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease
|
||||
| 4 | Completed |
Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
|
||||
| 5 | Completed |
Comparison of Two Test Methods-NASBA and Antigenemia-for Detecting Cytomegalovirus Infection
|
||||
| 6 | Completed |
Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients
|
||||
| 7 | Unknown † |
Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy
|
||||
| 8 | Terminated |
CMV Infection in Adolescent Males
|
||||
| 9 | Completed |
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
|
||||
| 10 | Unknown † |
Efficacy and Safety of Valcyte® as an Add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
|
||||
| 11 | Completed |
Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
|
||||
| 12 | Active, not recruiting |
gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females
|
||||
| 13 | Completed |
Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients
|
||||
| 14 | Completed |
Study of Prophylactic Vs Preemptive Valganciclovir
|
||||
| 15 | Completed |
Does Normal Brain Imaging Predict Normal Neurodevelopmental Outcome in Fetuses With Proven Cytomegalovirus Infection?
|
||||
| 16 | Completed |
Recombinant CMV gB Vaccine in Postpartum Women
|
||||
| 17 | Unknown † |
Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection
|
||||
| 18 | Not yet recruiting |
Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants
|
||||
| 19 | Completed |
Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
|
||||
| 20 | Completed |
The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|